HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported net income increased 382% to $2.2 million during the first quarter of 2009, compared with net income of $460,000 in the prior year period, driven by an 18% increase in total revenue to $58.9 million and a 23% increase in gross profit to $32.7 million in the first quarter of 2009. Earnings per diluted share for the first quarter of 2009 increased to $0.04, compared with earnings per diluted share of $0.01 in the prior year period.
